Speaker: Dr. Louis-Philippe Girard
Learning Objectives:
- Integrate new knowledge regarding the pathophysiology of ANCA Associated Vasculitis (AAV) into their existing understanding of this disease
- Synthesize knowledge regarding pathophysiology and how this informs therapeutic development and decisions
- Update their treatment paradigms with current guideline directed therapy
- Explore emerging therapies in the AAV realm
- Hybrid session - in person and on Zoom
